Reduced lung function, C-reactive protein, and increased risk of cardiovascular mortality

Circulation Journal

Volumn 78, Issue 9, 2014, Pages 2309-2316

  Min, Jin Young ^a   Min, Kyoung Bok ^b  

^a Seoul National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Coronary artery disease; Inflammation; Lung

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HAZARD RATIO; HUMAN; LUNG FUNCTION; MALE; MIDDLE AGED; RESPIRATORY TRACT PARAMETERS; SMOKING; SPIROMETRY; BLOOD; COMPARATIVE STUDY; FACTUAL DATABASE; LUNG; LUNG FUNCTION TEST; METABOLISM; MORTALITY; PATHOPHYSIOLOGY;

ADULT; AGED; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 84906810042     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0308     Document Type: Article

References (38)

1. Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: Relationship with inflammation- sensitive plasma proteins. Circulation 2002; 106: 2555-2560.
2. Kato J, Koike A, Hoshimoto-Iwamoto M, Nagayama O, Sakurada K, Sato A, et al. Relation between oscillatory breathing and cardiopulmonary function during exercise in cardiac patients. Circ J 2013; 77: 661-666.
3. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, et al. Lung function and incident coronary heart disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003; 158: 1171-1181.
4. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118: 656-664.
5. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
6. Wannamethee SG, Shaper AG, Rumley A, Sattar N, Whincup PH, Thomas MC, et al. Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: Possible associations with inflammation. Diabetes Care 2010; 33: 1990-1996.
7. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-715; discussion 715-716.
8. Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. Circ J 2013; 77: 1923-1932.
9. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
10. Sabia S, Shipley M, Elbaz A, Marmot M, Kivimaki M, Kauffmann F, et al. Why does lung function predict mortality? Results from the Whitehall II Cohort Study. Am J Epidemiol 2010; 172: 1415-1423.
11. Lee HM, Le H, Lee BT, Lopez VA, Wong ND. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010; 36: 1002-1006.
12. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1008-1011.
13. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
14. Centers for Disease Control and Prevention. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94 Vital Health Stat 1994; 1(32). http://www.cdc.gov/nchs/data/series/ sr_01/sr01_032.pdf (accessed June 2, 2013).
15. National Center for Health S. NHANES III Linked Mortality File. 2006. http://www.cdc.gov/nchs/data_access/data_linkage/mortality/ nhanes3_linkage.htm (accessed October 30, 2012).
16. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: Preliminary estimates. Natl Vital Stat Rep 2001; 49: 1-32.
17. American Thoracic Society. Standardization of spirometry: 1987 update: Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1285-1298.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
19. National Center for Health Statistics. NHANES III Reference Manuals and Reports. CD ROM No. 6-0178 (1096). Hyattsville, MD: Data Dissemination Branch, 1996.
20. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: Results from the Busselton Health Study. Ann Epidemiol 1999; 9: 297-306.
21. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007; 131: 1557-1566.
22. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 43: 1731-1737.
23. Batty GD, Gunnell D, Langenberg C, Smith GD, Marmot MG, Shipley MJ. Adult height and lung function as markers of life course exposures: Associations with risk factors and cause-specific mortality. Eur J Epidemiol 2006; 21: 795-801.
24. Chinn S, Gislason T, Aspelund T, Gudnason V. Optimum expression of adult lung function based on all-cause mortality: Results from the Reykjavik study. Respir Med 2007; 101: 601-609.
25. Jerrett M, Burnett RT, Pope CA 3rd, Ito K, Thurston G, Krewski D, et al. Long-term ozone exposure and mortality. N Engl J Med 2009; 360: 1085-1095.
26. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007; 356: 447-458.
27. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, et al. Ischemic and thrombotic effects of dilute dieselexhaust inhalation in men with coronary heart disease. N Engl J Med 2007; 357: 1075-1082.
28. Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: A prospective study. Thorax 2007; 62: 515-520.
29. Hancox RJ, Poulton R, Greene JM, Filsell S, McLachlan CR, Rasmussen F, et al. Systemic inflammation and lung function in young adults. Thorax 2007; 62: 1064-1068.
30. Jiang R, Burke GL, Enright PL, Newman AB, Margolis HG, Cushman M, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol 2008; 168: 602-610.
31. Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, et al. Change in C-reactive protein levels and FEV1 decline: A longitudinal population-based study. Respir Med 2006; 100: 2112-2120.
32. Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: The CARDIA Study. Int J Epidemiol 2006; 35: 1001-1008.
33. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61: 849-853.
34. Clearfield MB. C-reactive protein: A new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 2005; 105: 409-416.
35. Rifai N, Ridker PM. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin Chem 2001; 47: 403-411.
36. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002; 39: 935-942.
37. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
38. Lloyd-Jones DM, Martin DO, Larson MG, Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998; 129: 1020-1026.